EN
TR
CONTACT US
NEWS FROM US
Toggle navigation
ABOUT DEVA
MILESTONES
MESSAGE FROM THE CEO
MISSION
BOARD OF DIRECTORS
SHAREHOLDING STRUCTURE AND SUBSIDIARIES
DEVA HOLDİNG HEALTH, SAFETY AND ENVIRONMENT POLICY
INFORMATION SOCIETY SERVICES
OUR VALUES
MANUFACTURING SITES
AWARDS
DEVARGE
BOĞAZİÇİ COLOGNE
DEVA HOLDING QUALITY POLICY
DEVA HOLDING INFORMATION SECURITY POLICY
SUSTAINABILITY
DEVA HOLDING IN BRIEF
DEVA HOLDING ENERGY POLICY
INTERNATIONAL MARKETS
INTERNATIONAL MARKETS
PRODUCTS
INVESTOR RELATIONS
DIVIDEND POLICY
ANNUAL REPORTS
FINANCIAL STATEMENTS
ARTICLES OF INCORPORATION
TRADE REGISTER INFORMATION
SHAREHOLDING STRUCTURE
PRIVILEGED SHARES
COMPLIANCE REPORTS
COMMITTEES
POLICIES
GENERAL ASSEMBLY
ANNOUNCEMENTS
HUMAN RESOURCES
OUR HUMAN RESOURCES POLICY
CAREER AT DEVA
BEING A PART OF DEVA
CAREER OPPORTUNITIES
MEDIA
PRODUCTS
home
/
products
/
urınary system, connectıve tıssue
URINARY SYSTEM, CONNECTIVE TISSUE
BEGAMIR 50MG
Form:
Film coated tablets
Ingredients:
Mirabegron
